Drug: |
PX-478 |
|||
---|---|---|---|---|
Trial: |
Phase I Trial of PX-478 |
|||
Conditions: | Solid Tumors | |||
Trial Status: |
Completed |
TGen Clinical Research Services10460 N. 92nd Street, Suite 206 |
Principal Investigator: |
Daniel D. VonHoff, MD |
---|---|
Contact: |
Lynne Hull 480-323-1071 lhull@shc.org |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
TGen Clinical Research Services Website: |
http://www.tgen.org/research/index.cfm?pageid=1085 |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.